EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Enzyme-inhibition system for identifying potential antimalarials that target highly drug-resistant mutants of Plasmodium falciparum dihydrofolate reductase






Parasitology International 47(1): 69-78, March

Enzyme-inhibition system for identifying potential antimalarials that target highly drug-resistant mutants of Plasmodium falciparum dihydrofolate reductase

We reconstructed a variety of point mutations in recombinant Plasmodium falciparum dihydrofolate reductase (DHFR) to mimic the DHFR of pyrimethamine- and cycloguanil-resistant strains so far reported as a way to test the feasibility of using inhibition of the enzyme in the search for potential inhibitors against drug resistant parasites. The steady-state kinetic parameters for all of the mutants gave kcats in the range 26.6-93 s-1 that were similar or close to that of the wild-type enzyme. However, the elevated Km values resulted in kcat/Km that showed a 4- to 28-fold reduction in catalytic efficiency as compared with the wild-type. The mutants, either single at position 108 or multiple at 16, 51, 59, 108 or 164 showed progressive decreases in response towards pyrimethamine and cycloguanil in the range of 4.3- to 9667-fold and 3.4- to 760-fold, respectively which correlated with the in vivo observation for parasite inhibition. The mutants were, however, moderately cross-resistant to methotrexate, aminopterin and novel pyrrolopyrimidine antifolates. In order to assess the selectivity of the inhibition, we employed recombinant human DHFR and found some discrepancy in the selectivity when bovine DBFR was used. By using human DHFR in the selective analysis, a pyrrolo-pyrimidine (P-5) was revealed to be the most selective test compound that contains a phenyltrimethoxy moiety as trimethoprim, a highly selective antibacterial antifolate. Our current system of the enzyme inhibition would complement other assay systems for readily identifying new antifolates based on potency and selectivity against the drug-resistant malaria.

Accession: 003127137

DOI: 10.1016/s1383-5769(98)00004-x

Download PDF Full Text: Enzyme-inhibition system for identifying potential antimalarials that target highly drug-resistant mutants of Plasmodium falciparum dihydrofolate reductase



Related references

Tarnchompoo, B.; Sirichaiwat, C.; Phupong, W.; Intaraudom, C.; Sirawaraporn, W.; Kamchonwongpaisan, S.; Vanichtanankul, J.; Thebtaranonth, Y.; Yuthavong, Y., 2002: Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum. The reduced binding of pyrimethamine to Ser108Asn (S108N) mutants of parasite dihydrofolate reductase (DHFR), which forms the basis of resistance of Plasmodium falciparum to pyrimethamine, is largely due to steric constraint imposed by the bulky s...

Tipsuwan, W.; Srichairatanakool, S.; Kamchonwongpaisan, S.; Yuthavong, Y.; Uthaipibull, C., 2011: Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model. The prevalence of drug resistance amongst the human malaria Plasmodium species has most commonly been associated with genomic mutation within the parasites. This phenomenon necessitates evolutionary predictive studies of possible resistance mutati...

Sirawaraporn, W.; Prapunwattana, P.; Sirawaraporn, R.; Yuthavong, Y.; Santi, D.V., 1993: The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. Gene synthesis, expression, and anti-folate-resistant mutants. A 693-base pair gene coding for the 27,132-dalton dihydrofolate reductase (DHFR) domain of the thymidylate synthase-dihydrofolate reductase (TS-DHFR) bifunctional protein of Plasmodium falciparum was designed to have Escherichia coli codon prefere...

Sirawaraporn, W.; Sathitkul, T.; Sirawaraporn, R.; Yuthavong, Y.; Santi, D.V., 1997: Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Single and multiple mutations at residues 16, 51, 59, 108, and 164 of Plasmodium falciparum dihydrofolate reductase (pfDHFR) have been linked to antifolate resistance in malaria. We prepared and characterized all seven of the pfDHFR mutants found...

Anonymous, 2007: Identifying novel drug targets for Plasmodium falciparum thymidylate synthase dihydrofolate reductase

Franca, T.C.C.; Medeiros, A.L.R. de; Santos, E.C.P. dos; Santos Filho, O.A.; Figueroa Villar, J.D., 2004: A complete model of the Plasmodium falciparum bifunctional enzyme dihydrofolate reductase-thymidylate synthase. A model to design new antimalarials. We propose a theoretical model for the P. falciparum bifunctional enzyme dihydrofolate reductase-thymidylate synthase (pfDHFR-TS), which includes the 55 amino acid residues ignored in the crystallographic model. The electrostatic potential calcula...

Hastings, M.D.; Bates, S.J.; Blackstone, E.A.; Monks, S.M.; Mutabingwa, T.K.; Sibley, C.Hopkins., 2003: Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. In 2000 we used a sensitive technique to examine 9 isolates from malaria patients in Muheza, Tanzania who had failed treatment with sulfadoxine-pyrimethamine (SP). Three isolates carried, at low levels, the leucine to isoleucine change at amino ac...

Hastings, M.D.; Bates, S.J.; Blackstone, E.A.; Monks, S.M.; Mutabingwa, T.K.; Sibley, C.H., 2002: Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. In 2000 we used a sensitive technique to examine 9 isolates from malaria patients in Muheza, Tanzania who had failed treatment with sulfadoxine-pyrimethamine (SP). Three isolates carried, at low levels, the leucine to isoleucine change at amino ac...

Bates, S.J.; Winstanley, P.A.; Watkins, W.M.; Alloueche, A.; Bwika, J.; Happi, T.Christian.; Kremsner, P.G.; Kublin, J.G.; Premji, Z.; Sibley, C.Hopkins., 2004: Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites. In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mutations in the Plasmodium falciparum dihydrofolate reductase gene (dhfr) associated with increased risk of clinical failure of sulfadoxine-pyrimeth...

Anonymous, 2008: Evaluation of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.